Oral Biologics Market, By Drug Class (Glucagon-like Peptide 1 (GLP-1) Receptor Agonist, Hormone, Rec

Published Date: | Report Code : HC2067007


Oral Biologics Market, By Drug Class (Glucagon-like Peptide 1 (GLP-1) Receptor Agonist, Hormone, Recombinant Enzyme, Guanylate Cyclase-C Agonist, Somatostatin Analogue, and Others), By Disease Indication (Diabetes, Hyperoxaluria, Acromegaly, Irritable Bowel Syndrome (IBS) & Chronic Idiopathic Constipation (CIC), and Others (Inflammatory Bowel Disease (IBD), Hypoparathyroidism, and Others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America) – Market Size & Forecasting To 2028

COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.

Domain : Healthcare

Report Code : HC2067007

Status : Upcoming

The Oral Biologics Market report points out national and global business prospects and competitive conditions for oral biologics. Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for oral biologics. The oral biologics market has been segmented by drug class (glucagon-like peptide 1 (glp-1) receptor agonist, hormone, recombinant enzyme, guanylate cyclase-c agonist, somatostatin analogue, and others), by disease indication (diabetes, hyperoxaluria, acromegaly, irritable bowel syndrome (ibs) & chronic idiopathic constipation (cic), and others (inflammatory bowel disease (ibd), hypoparathyroidism, and others)), by distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies). Historical background for the demand of oral biologics has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand oral biologics have also been established with potential gravity. Major regions covered in the study include North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Market Segmentation:

By Drug Class:

  • Glucagon-like Peptide 1 (GLP-1) Receptor Agonist
  • Hormone
  • Recombinant Enzyme
  • Guanylate Cyclase-C Agonist
  • Somatostatin Analogue
  • Others

By Disease Indication:

  • Diabetes
  • Hyperoxaluria
  • Acromegaly
  • Irritable Bowel Syndrome (IBS) & Chronic Idiopathic Constipation (CIC)
  • Others (Inflammatory Bowel Disease (IBD)
  • Hypoparathyroidism
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

North America Oral Biologics Market

  • North America, by Country
    • US
    • Canada
    • Mexico
  • North America, by Drug Class
  • North America, by Disease Indication
  • North America, by Distribution Channel

Europe Oral Biologics Market

  • Europe, by Country
    • Germany
    • Russia
    • UK
    • France
    • Italy
    • Spain
    • The Netherlands
    • Rest of Europe 
  • Europe, by Drug Class
  • Europe, by Disease Indication
  • Europe, by Distribution Channel

Asia Pacific Oral Biologics Market

  • Asia Pacific, by Country
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Rest of Asia Pacific 
  • Asia Pacific, by Drug Class
  • Asia Pacific, by Disease Indication
  • Asia Pacific, by Distribution Channel

Middle East & Africa Oral Biologics Market

  • Middle East & Africa, by Country 
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East & Africa
  • Middle East & Africa, by Drug Class
  • Middle East & Africa, by Disease Indication
  • Middle East & Africa, by Distribution Channel

South America Oral Biologics Market

  • South America, by Country 
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • South America, by Drug Class
  • South America, by Disease Indication
  • South America, by Distribution Channel

Major Companies: Novo Nordisk A/S, Biocon Limited, Oramed Pharmaceuticals, Inc., Rani Therapeutics, Entera Bio Ltd., Allergan plc, Emisphere Technologies, Inc., Enteris BioPharma, Inc., Chiasma, Inc., and Allena Pharmaceuticals, Inc.

Years Covered in the Study:

Historic Year: 2017-2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2028

Objectives of this report:

  • To estimate market size for oral biologics market on regional and global basis.
  • To identify major segments in oral biologics market and evaluate their market shares and demand.
  • To provide a competitive scenario for the oral biologics market with major developments observed by key companies in the historic years.
  • To evaluate key factors governing the dynamics of oral biologics market with their potential gravity during the forecast period.

Reasons to Buy This Report:

  • Provides niche insights for decision about every possible segment helping in strategic decision making process.
  • Market size estimation of the oral biologics market on a regional and global basis.
  • A unique research design for market size estimation and forecast.
  • Identification of major companies operating in the market with related developments
  • Exhaustive scope to cover all the possible segments helping every stakeholder in the oral biologics


This study is customized to meet your specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country
  • Product Specific Competitive Analysis

For more information, contact: [email protected]

License Offering

Single User (PDF)


Multi User (PDF)


Enterprise User (PDF)


Get Regional Report @ USD 2000 Only

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision


Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy